Aravind Sanjeevaiah is an Oncology physician affiliated with The University of Texas Southwestern Medical Center. OpenAlex indexes 57 publications with 748 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2380 S. I-35e
Waxahachie, TX 75165
Telephone
469-843-6000Provider last certified this registry record 5 Jun 2024.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20253 payments
- E.R. Squibb & Sons, L.L.C.Program year20253 payments
- Gilead Sciences, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
22.5%Aromatase Inhibitor7.5%Letrozole100%Part D≥18 patientsKinase inhibitor4.4%Tagrisso44%Imatinib Mesylate30%Inlyta26%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
21.5%Serotonin-3 Receptor Antagonist17.7%Ondansetron Hcl72%Ondansetron Odt28%Part D≥63 patientsCorticosteroid2.6%Prednisone100%Part D≥11 patients+ 1 more class in this area
Nervous system
16.8%Opioid Agonist6.1%Morphine Sulfate Er53%Tramadol Hcl28%Fentanyl18%Part D<11 patientsPhenothiazine4.5%Prochlorperazine Maleate100%Part D≥26 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Intensifying supportive care is associated with improved survival in gastric cancer patients with malignant ascites
Journal of Surgical Oncology
2023 - Neutrophil-to-lymphocyte ratio and clinical outcomes in liver resection for metastatic colorectal cancer.
Journal of Clinical Oncology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Toto, MD
The University of Texas Southwestern Medical Center
Margaret Pearle, MD, PhD
The University of Texas Southwestern Medical Center
George Buchanan, MD
The University of Texas Southwestern Medical Center
Vitaly Margulis, MD
The University of Texas Southwestern Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”